2019

1. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

   Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854

2. Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease

   Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386

3. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

   Therapeutic Advances in Gastroenterology, Vol. 12